2025 · 3rd Quarter (July 1 - Sep 30)

ROYAL BIOLOGICS

Filed by THE MCMANUS GROUP.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: $40,000.00
Expenses: Not reported
Registrant: THE MCMANUS GROUP
Client: ROYAL BIOLOGICS
Filing UUID: 9475ba9b-afee-4f0b-92b5-ff6458ba61e0
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Issues related to skin substitute payment in 2026 Physician Fee Schedule Proposed Rule (CMS-1832-P). Skin Substitute Access and Payment Reform Act of 2025 (S. 2561).

Literal federal measure citations: S. 2561

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.